Michael Higgins
Stock Analyst at Ladenburg Thalmann
(1.81)
# 3,333
Out of 5,124 analysts
22
Total ratings
33.33%
Success rate
5.24%
Average return
Main Sectors:
Stocks Rated by Michael Higgins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics | Downgrades: Neutral | n/a | $31.12 | - | 4 | May 9, 2024 | |
| FBRX Forte Biosciences | Upgrades: Buy | $69 | $27.27 | +152.11% | 3 | Apr 8, 2024 | |
| OVID Ovid Therapeutics | Reiterates: Buy | $7 | $1.63 | +329.45% | 1 | May 2, 2023 | |
| SCYX SCYNEXIS | Reiterates: Buy | $15 | $0.63 | +2,271.92% | 1 | Apr 3, 2023 | |
| ARTL Artelo Biosciences | Reiterates: Buy | $360 | $1.22 | +29,408.20% | 2 | Apr 3, 2023 | |
| RYTM Rhythm Pharmaceuticals | Reiterates: Buy | $35 | $107.04 | -67.30% | 3 | Mar 2, 2023 | |
| PTN Palatin Technologies | Maintains: Buy | $2 → $50 | $15.38 | +225.10% | 1 | Sep 9, 2022 | |
| PHGE BiomX | Maintains: Buy | $2,470 → $1,520 | $1.87 | +81,183.42% | 2 | May 12, 2022 | |
| NVAX Novavax | Downgrades: Sell | $105 | $6.72 | +1,462.50% | 2 | Aug 5, 2020 | |
| VIRT Virtu Financial | Upgrades: Buy | $29 | $33.32 | -12.97% | 2 | Jan 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | n/a | $6.03 | - | 1 | Sep 27, 2017 |
Viridian Therapeutics
May 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $31.12
Upside: -
Forte Biosciences
Apr 8, 2024
Upgrades: Buy
Price Target: $69
Current: $27.27
Upside: +152.11%
Ovid Therapeutics
May 2, 2023
Reiterates: Buy
Price Target: $7
Current: $1.63
Upside: +329.45%
SCYNEXIS
Apr 3, 2023
Reiterates: Buy
Price Target: $15
Current: $0.63
Upside: +2,271.92%
Artelo Biosciences
Apr 3, 2023
Reiterates: Buy
Price Target: $360
Current: $1.22
Upside: +29,408.20%
Rhythm Pharmaceuticals
Mar 2, 2023
Reiterates: Buy
Price Target: $35
Current: $107.04
Upside: -67.30%
Palatin Technologies
Sep 9, 2022
Maintains: Buy
Price Target: $2 → $50
Current: $15.38
Upside: +225.10%
BiomX
May 12, 2022
Maintains: Buy
Price Target: $2,470 → $1,520
Current: $1.87
Upside: +81,183.42%
Novavax
Aug 5, 2020
Downgrades: Sell
Price Target: $105
Current: $6.72
Upside: +1,462.50%
Virtu Financial
Jan 4, 2019
Upgrades: Buy
Price Target: $29
Current: $33.32
Upside: -12.97%
Sep 27, 2017
Reinstates: Buy
Price Target: n/a
Current: $6.03
Upside: -